This is to inform you that the Board of Directors of the Company has at its meeting held today i.e. May 2, 2025 based on recommendation of the Nomination and Remuneration Committee, approved inter-alia continuation of Directorship of Mr. Harsh Mariwala (DIN: 00210342) as a Non-Executive Director, pursuant to Regulation 17(1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
MARICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Midcap 150 and 4.0 pts more than its Edible Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Marico's board approved audited Q4 and FY25 results with the statutory auditor issuing an unmodified opinion. Consolidated FY25 revenue rose about 12% to Rs. 10,831 crore, while net profit grew around 10% to Rs. 1,658 crore; Q4 revenue came in at Rs. 2,730 crore and net profit at Rs. 345 crore. The board recommended a final dividend of Rs. 7 per share, taking the total FY25 dividend to Rs. 10.50 per share (including the Rs. 3.50 interim dividend declared in January 2025), with a record date of August 1, 2025 and payment by September 7, 2025. The 37th AGM is set for August 8, 2025 via video conferencing. The board also approved continuation of founder Harsh Mariwala as a Non-Executive Director under SEBI's Reg 17(1A), appointed Dr. K.R. Chandratre as Secretarial Auditor for five years, and amended the ESOP 2016 to allow cashless exercise of options.
Strong topline and profit growth, a healthy and consistent dividend payout, and continued promoter presence on the board are positive signals for shareholders. The record date of August 1, 2025 is the key date for dividend eligibility.